Patents by Inventor Oliver Vetter

Oliver Vetter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5998418
    Abstract: The present invention relates to novel injection and infusion solutions of the following composition:a) 0.1 to 20% by weight of enrofloxacin, based on the total weight of the solution, in the form of its salts with polyhydroxycarboxylic acids or amino acids or mixtures thereof,b) polyhydroxycarboxylic acids, amino acids or mixtures thereof in 0.1 to 5 molar excess, based on enrofloxacin;c) optionally 0.1 to 30% by weight of formulation aids, based on the total weight of the solution;d) water to 100% by weight.
    Type: Grant
    Filed: July 7, 1997
    Date of Patent: December 7, 1999
    Assignee: Bayer Aktiengesellschaft
    Inventors: Gerhard Bonse, Martin Hamm, Hanns-Peter Muller, Arundev Haribhai Naik, deceased, Martin Scheer, Michael Stegemann, Oliver Vetter
  • Patent number: 5808076
    Abstract: The present invention relates to the preparation of orally administrable formulations of quinolone- or naphthyridonecarboxylic acids by mixing quinolone- or naphthyridonecarboxylic acids as such or in the form of their water-soluble salts or derivatives, preferably in the form of their aqueous salt solutions, with embonic acid as such or in the form of its water-soluble salts or derivatives, preferably in the form of its aqueous salt solutions, in the presence of an excipient, optionally in the presence of auxiliaries, when using dry mixtures in the presence of water, and optionally converting the mixture obtained into further ready-to-use forms.
    Type: Grant
    Filed: December 6, 1996
    Date of Patent: September 15, 1998
    Assignee: Bayer Aktiengesellschaft
    Inventors: Oliver Vetter, Reinhold Lohr, Matthias Kuhn, Hubert Rast, Martin Scheer, Ernst Heinen, Francisco Cabrera